Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-04
1989-08-08
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546218, A61K 31435, C07D21152
Patent
active
048553077
ABSTRACT:
The present invention relates to the novel acetic acid ester of 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butano ne, as well as pharmaceutically acceptable acid addition salts thereof, a method of preparation, pharmaceutical compositions and a method of treating psychoses by administering said ester to an animal or human body.
REFERENCES:
patent: 3408356 (1968-10-01), Horovitz
patent: 4070473 (1978-01-01), Hernestom et al.
Chemical Abstracts: 97 60926U; E. Suy et al., "Bioavailability and Clinical Effects of Two Different Concentrations of Haloperidol decanoate", (1982).
Chemical Abstracts 94: 180676X, C. Niemegeers, "Parental Psychotropic Preparation with Long Term Action", (1981).
H. Lundbeck A/S
Hueschen Gordon W.
Raymond Richard L.
Russell Mark W.
LandOfFree
Acetic acid ester of haloperidol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetic acid ester of haloperidol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetic acid ester of haloperidol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905807